Genetic response to Covid-19 infectio
Not Applicable
- Conditions
- Health Condition 1: U07-U07- Provisional assignment of new diseases of uncertain etiology or emergency use
- Registration Number
- CTRI/2021/10/037036
- Lead Sponsor
- Cancyte Technologies Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients who can read and understand English and given their informed consent
gave Informed Consent for the study
Covid-19 RT-PCR positive patients
Non-Vaccinated , Non-infected , asymptomatic and symptomatic volunteers - (Control Group)
Exclusion Criteria
Patient who have not given consent for this study
Pregnancy
People with the history of Cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To identify immunological and inflammatory response of the host immune genes to Covid-19 infection.Timepoint: 2 Time points; Day 0 and Day 14
- Secondary Outcome Measures
Name Time Method To see the percentage change in immune and inflammatory gene panel selected for the study against controls.Timepoint: 2 Time points; Day 0 and Day 14